These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2745246)

  • 1. Penetration of enoxacin into lung tissue.
    Newsom SW; Eden CG; Wells FC; Meredith P
    J Antimicrob Chemother; 1989 Jan; 23(1):113-5. PubMed ID: 2745246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A study on enoxacin concentration in human prostatic tissue].
    Kitamura Y; Kataumi Z; Nakamura T; Takeda H
    Hinyokika Kiyo; 1990 Jan; 36(1):101-2. PubMed ID: 1689927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo diffusion of enoxacin in healthy renal and adenomatous prostate tissue in man.
    Charton M; Timbal Y
    Eur Urol; 1990; 17(3):252-6. PubMed ID: 1693576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of enoxacin and its oxometabolite after multiple oral dosing and penetration into prostatic tissue.
    Hamel B; Mottet N; Audran M; Costa P; Bressolle F
    J Antimicrob Chemother; 2000 Dec; 46(6):993-6. PubMed ID: 11102420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Enoxacin concentration in human prostatic tissue after 3-day administration].
    Morita M; Kato M; Kuji S; Hasuda A
    Hinyokika Kiyo; 1988 Jul; 34(7):1293-6. PubMed ID: 2459943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of enoxacin and its penetration into bronchial secretions and lung tissue.
    Wijnands WJ; Vree TB; Baars AM; van Herwaarden CL
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():67-77. PubMed ID: 3162904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bronchopulmonary penetration of enoxacin].
    Loos U; Sörgel F; Marklein G; Kraeft H
    Infection; 1989; 17 Suppl 1():S23-4. PubMed ID: 2807559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetration of enoxacin into middle ear effusion.
    Sundberg L; Edén T
    Acta Otolaryngol; 1990; 109(5-6):438-43. PubMed ID: 2360450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enoxacin penetration into human prostatic tissue.
    Bergeron MG; Roy R; Lessard C; Foucault P
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1433-4. PubMed ID: 3196004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Enoxacin concentrations in lung tissue].
    Adam D; Präuer H; Sörgel F; Zürcher J
    Infection; 1989; 17 Suppl 1():S21-2. PubMed ID: 2807558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetration of enoxacin into bronchial secretions.
    Fong IW; Vandenbroucke A; Simbul M
    Antimicrob Agents Chemother; 1987 May; 31(5):748-51. PubMed ID: 3475036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of enoxacin, ofloxacin, and norfloxacin concentration in human benign prostatic tissue].
    Yasumoto R; Asakawa M
    Hinyokika Kiyo; 1988 Aug; 34(8):1519-21. PubMed ID: 3195414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple chromatographic method for determining norfloxacin and enoxacin in pharmacokinetic study assessing CYP1A2 inhibition.
    Kobayashi T; Homma M; Momo K; Kobayashi D; Kohda Y
    Biomed Chromatogr; 2011 Apr; 25(4):435-8. PubMed ID: 20662110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The diffusion of enoxacin into the prostatic fluid in the chronic prostatitis patient].
    Tanaka K; Nakano Y; Ono Y; Hirabayashi S; Yamada S
    Hinyokika Kiyo; 1988 Nov; 34(11):2067-9. PubMed ID: 3242374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue penetration and clinical efficacy of enoxacin in respiratory tract infections.
    Wood MJ
    Clin Pharmacokinet; 1989; 16 Suppl 1():38-45. PubMed ID: 2653694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enoxacin distribution in human tissues after multiple oral administration.
    Malmborg AS; Rannikko S
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():57-60. PubMed ID: 3162902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of renal impairment and haemodialysis on single dose pharmacokinetics of oral enoxacin.
    Nix DE; Schultz RW; Frost RW; Sedman AJ; Thomas DJ; Kinkel AW; Schentag JJ
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():87-95. PubMed ID: 3162906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue penetration and clinical efficacy of enoxacin in urinary tract infections.
    Childs SJ
    Clin Pharmacokinet; 1989; 16 Suppl 1():32-7. PubMed ID: 2653693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution kinetics of enoxacin and its metabolite oxoenoxacin in excretory fluids of healthy volunteers.
    Jaehde U; Sörgel F; Naber KG; Zürcher J; Schunack W
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2092-7. PubMed ID: 8540722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of tissue penetration and clinical efficacy of enoxacin in skin and skin structure infections and in osteomyelitis.
    Pankey GA
    Clin Pharmacokinet; 1989; 16 Suppl 1():46-51. PubMed ID: 2653695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.